Table 1 Baseline characteristics of eligible participants
Overall (n = 3946) | Did not report infection (n = 2569) | Reported infection (n = 1377) | |||||
|---|---|---|---|---|---|---|---|
Unvaccinated (n = 380) | Vaccinated after infection (n = 348) | 1-Dose pre-infection (n = 123) | 2-Doses (n = 215) | 3-Doses (n = 311) | |||
Age (SD) | 50.62 (16.17) | 52.70 (16.38) | 42.16 (13.58) | 46.63 (14.11) | 46.77 (15.18) | 46.83 (15.51) | 46.18 (13.64) |
Age categories | |||||||
18–30 | 9.20 | 8.50 | 13.20 | 10.90 | 7.30 | 8.40 | 7.00 |
31–50 | 31.20 | 30.50 | 38.40 | 30.80 | 22.00 | 29.30 | 28.00 |
51–70 | 30.20 | 36.00 | 14.40 | 28.40 | 16.30 | 18.20 | 17.70 |
71+ | 29.40 | 25.00 | 34.0 | 29.90 | 54.40 | 44.10 | 47.30 |
Sex (Female) (%) | 59.70 | 57.31 | 64.10 | 62.50 | 62.30 | 68.90 | 67.60 |
Ethnicity (Jewish) (%) | 75.10 | 78.29 | 67.70 | 60.00 | 62.20 | 78.40 | 76.90 |
Income | |||||||
<5300 NIS | 34.70 | 35.10 | 44.60 | 30.20 | 28.20 | 33.00 | 26.10 |
5300–15,000 NIS | 34.50 | 32.50 | 34.90 | 43.60 | 46.20 | 31.80 | 39.30 |
>15,000 NIS | 30.80 | 32.40 | 20.50 | 26.10 | 25.60 | 35.20 | 34.60 |
